| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/18/2022 | 408.47% | Ascendiant Capital | → $0.75 | Initiates Coverage On | → Buy |
| 03/08/2022 | 306.78% | Maxim Group | → $0.6 | Initiates Coverage On | → Buy |
Guardion Health Sciences Questions & Answers
The latest price target for Guardion Health Sciences (NASDAQ: GHSI) was reported by Ascendiant Capital on July 18, 2022. The analyst firm set a price target for $0.75 expecting GHSI to rise to within 12 months (a possible 408.47% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Guardion Health Sciences (NASDAQ: GHSI) was provided by Ascendiant Capital, and Guardion Health Sciences initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Guardion Health Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Guardion Health Sciences was filed on July 18, 2022 so you should expect the next rating to be made available sometime around July 18, 2023.
While ratings are subjective and will change, the latest Guardion Health Sciences (GHSI) rating was a initiated with a price target of $0.00 to $0.75. The current price Guardion Health Sciences (GHSI) is trading at is $0.15, which is within the analyst's predicted range.